Asian Scientist Newsroom
ABOUT
Asian Scientist Magazine is an award-winning science and technology magazine that highlights R&D news stories from Asia to a global audience. The magazine is published by Singapore-headquartered Wildtype Media Group.
Stories by Asian Scientist Newsroom
Gene Associated With Cancer Drug Resistance Identified
Variations in the TEKT4 gene result in microtubule destabilization, possibly explaining how breast cancer cells develop resistance to the drug paclitaxel.
ADB Invests US$60 Million To Boost Healthcare In Asia
The Asian Development Bank invests US$60 million in OrbiMed Asia to improve the delivery of healthcare services.
Training The Immune System To Target Brain Cancer
By exploiting the fact that many brain tumors harbor cytomegalovirus, scientists have used the patient's immune system to target brain cancer.
Shire Acquires Fibrotech For US$75 Million
Shire's acquisition of the University of Melbourne-affiliated Fibrotech highlights the potential for commercialization in public-private partnerships.
Taking Omega-3 Supplements Doesn’t Make Smarter Kids
Children whose mothers took omega-3 supplements while pregnant are no better at cognitive tasks than children whose mothers took placebos, study says.
Agilent & SNU To Launch Drug Development Center
Agilent Technologies collaborates with the Seoul National University on a new drug development center to be housed in the university's college of pharmacy.
Scientists Uncover How EBV Hides
A new study has shown that the Epstein-Barr virus flies below the immune system's radar by restricting the production of the protein EBNA1.
High CO2 Reduces Nutritional Value Of Key Crops
Researchers have found that the elevated carbon dioxide levels of 2050 could lead to lower levels of micronutrients and protein in staple crops.
New Alzheimer’s Drugs Developed By Eisai & Biogen Idec
Eisai and Biogen Idec are developing two new Alzheimer's drugs at Phase II clinical trials, E2609 and BAN2401.
Gene Associated With Cancer Drug Resistance Identified
Variations in the TEKT4 gene result in microtubule destabilization, possibly explaining how breast cancer cells develop resistance to the drug paclitaxel.
ADB Invests US$60 Million To Boost Healthcare In Asia
The Asian Development Bank invests US$60 million in OrbiMed Asia to improve the delivery of healthcare services.
Training The Immune System To Target Brain Cancer
By exploiting the fact that many brain tumors harbor cytomegalovirus, scientists have used the patient's immune system to target brain cancer.
Shire Acquires Fibrotech For US$75 Million
Shire's acquisition of the University of Melbourne-affiliated Fibrotech highlights the potential for commercialization in public-private partnerships.
Taking Omega-3 Supplements Doesn’t Make Smarter Kids
Children whose mothers took omega-3 supplements while pregnant are no better at cognitive tasks than children whose mothers took placebos, study says.
Agilent & SNU To Launch Drug Development Center
Agilent Technologies collaborates with the Seoul National University on a new drug development center to be housed in the university's college of pharmacy.
Scientists Uncover How EBV Hides
A new study has shown that the Epstein-Barr virus flies below the immune system's radar by restricting the production of the protein EBNA1.
High CO2 Reduces Nutritional Value Of Key Crops
Researchers have found that the elevated carbon dioxide levels of 2050 could lead to lower levels of micronutrients and protein in staple crops.
New Alzheimer’s Drugs Developed By Eisai & Biogen Idec
Eisai and Biogen Idec are developing two new Alzheimer's drugs at Phase II clinical trials, E2609 and BAN2401.









